This lecture will explore the expanding role of photobiomodulation, or Low Level Light Therapy (LLLT), in optometric practice. From its increasingly common application in managing anterior segment conditions and dry eye disease, to the latest advancements showing promising results in reducing drusen volume and improving visual acuity in patients with dry age-related macular degeneration (AMD), the session will highlight the growing body of clinical evidence supporting its use.

Learning outcome(s):

Practitioners will identify treatment options using photobiomodulation or Low Level Light Therapy (LLLT) in clinical practice, relative to their scope of practice (s.7).